Agoracom Blog
«
»

INTERVIEW: GrowPros (GCI:CSE) Natural Pharmaceuticals Derived From Cannabis and Other Medicinal Plants @growprosmmp $GCI.ca

Posted by AGORACOM-JC at 9:46 AM on Wednesday, September 14th, 2016

Comprised Of Two Divisions

Pharmaceutical Division – PhytoPain Pharma

  • A new subsidiary created June 2, 2016. 80% Ownership
  • Mission is the development and commercialization of botanical based pharmaceuticals
  • A clinical stage drug development company engaged in the development of medication to alleviate symptoms related to: Pain,
    Insomnia, anxiety disorder, in patients suffering from Cancer and other, chronic and terminal diseases

WHY DOCTORS NEED PHARMA MARIJUANA SOLUTIONS

  • A Physician’s decision to prescribe a new drug or even a natural health product has to be based on Evidence-Based Medicine > A legal, ethical requirement
  • Currently, no body of evidence exists to not support the prescription or recommendation of medical marijuana in any medical condition, including terminal cancer
  • The GrowPros pharmaceutical product development plan would provide the data necessary for physicians to prescribe or recommend our products

Hub On AGORACOM / Watch Interview Now!

Tags: , , ,

This entry was posted on Wednesday, September 14th, 2016 at 9:46 am and is filed under AGORACOM Via Satellite, All Recent Posts, Medical Marijuana Stocks. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.